PEOPLE ON THE MOVE
International AIDS Vaccine Initiative
IAVI, the International AIDS Vaccine Initiative, will be led by Merck & Co. veteran Mark Feinberg from September 8.
Feinberg spent 11 years in vaccine and infectious disease roles at Merck & Co. before accepting President and CEO positions at IAVI. Most recently, he was Chief Public Health and Science Officer for Merck Vaccines.
He was particularly involved in commercialisation of vaccines for rotavirus, HPV, and Shingles. He also helped establish the MSD-Wellcome Trust Hilleman Laboratories in India to develop vaccines for low-income countries. Feinberg led Merck & Co.’s partnerships on its promising Ebola vaccine.
